|
ELVN Enliven Therapeutics Inc 1672619 |
| Balance Sheet |
|
Current Assets
|
296,997,000 |
|
Assets
|
305,430,000 |
|
Current Liabilities
|
17,027,000 |
|
Liabilities
|
17,027,000 |
|
Equity
|
288,403,000 |
|
Shares Out
|
47,237,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-55,989,000 |
|
Investing Cash Flow
|
-36,724,000 |
| Market Analysis |
Market Cap
|
1,050,318,726 |
|
Price
|
20.95 |
|
BVPS
|
6.11 |
|
PB
|
3.40 |
|
EPS
|
-1.93 |
|
PS
|
4.19 |
|
FCF
|
-92,713,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ELVN documents filed with the SEC.
ELVN Filings
Clear
